Citation Impact
Citing Papers
Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network
2005
Nosocomial Invasive Aspergillosis in Lymphoma Patients Treated with Bone Marrow or Peripheral Stem Cell Transplants
1993
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
1998 Standout
Early Lymphocyte Recovery Predicts Superior Survival after Autologous Stem Cell Transplantation in Non-Hodgkin Lymphoma: A Prospective Study
2008
Southwestern Internal Medicine Conference: Clinical Use of Hematopoietic Growth Factors
1993
Myeloid-derived suppressor cells coming of age
2018 Standout
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
2000 Standout
Stem cells from bone marrow, umbilical cord blood and peripheral blood for clinical application: current status and future application
1996
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Platelet functions and clinical effects in acute myelogenous leukemia
2007
Contribution of platelets to tumour metastasis
2011 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Aerobic bacterial and fungal infections in peripheral blood stem cell transplants
2001
GM-CSF Gene-Transduced Tumor Vaccines
2005
Juvenile idiopathic arthritis
2007 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
2008 Standout
Absolute Lymphocyte Count on Day 30 Is a Surrogate for Robust Hematopoietic Recovery and Strongly Predicts Outcome after T Cell-Depleted Allogeneic Stem Cell Transplantation
2007
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
1995 Standout
Treatment of Non-Hodgkin's Lymphoma
1993
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
2006 Standout
FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1998
Chronic graft-versus-host disease
2003 Standout
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.
1994
Graft-versus-host disease
2009 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Radioimmunotherapy for Non-Hodgkin's Lymphoma
2005
Monitoring of Epstein‐Barr virus load after hematopoietic stem cell transplantation for early intervention in post‐transplant lymphoproliferative disease
2008
Botanical polysaccharides: Macrophage immunomodulation and therapeutic potential
2005 Standout
Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer
2014 StandoutNobel
Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation
2002
TREG-cell therapies for autoimmune rheumatic diseases
2014 StandoutNobel
The STATs of cancer — new molecular targets come of age
2004 Standout
A Comparative Review of Colony-Stimulating Factors
1997
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Immunological reconstitution after hematopoietic cell transplantation – its relation to the contents of the graft
2008
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
Humoral immunity to viral and bacterial antigens in lymphoma patients 4–10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines
2001
Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis
2005
STATs: transcriptional control and biological impact
2002 Standout
Practice Guidelines for Diseases Caused by Aspergillus
2000
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
1997
Hematopoietic Stem Cell Transplantation in Hemophagocytic Lymphohistiocytosis: A Single-Center Report of 48 Patients
2006
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?
2001
Prognostic Significance of Anaplastic Lymphoma Kinase (ALK) Protein Expression in Adults With Anaplastic Large Cell Lymphoma
1999
Bexxar®: Novel Radioimmunotherapy for the Treatment of Low-Grade and Transformed Low-Grade Non-Hodgkin's Lymphoma
2004
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Reconstitution of the T-Cell Compartment After Bone Marrow Transplantation: Restoration of the Repertoire by Thymic Emigrants
1998
Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T/Null-Cell Lymphoma
2002
Prognostic Significance of Anaplastic Lymphoma Kinase (ALK) Protein Expression in Adults With Anaplastic Large Cell Lymphoma
1999
Complexity and challenges in defining myeloid-derived suppressor cells
2014
Aspergillus fumigatusand Aspergillosis
1999 Standout
Granulocyte Colony-Stimulating Factor Reduces the Capacity of Blood Mononuclear Cells to Induce Graft-Versus-Host Disease: Impact on Blood Progenitor Cell Transplantation
1997
ALK-Positive Lymphoma: A Single Disease With a Broad Spectrum of Morphology
1998
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma
2003
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Hematological Problems in Pediatric Intensive Care
2013 Standout
Works of JM Vose being referenced
Incidence of myelodysplastic syndromes (tMDS) and acute myeloid leukemia (tAML) in patients with low-grade non-Hodgkin's lymphoma (LG-NHL) treated with Bexxar (TM).
2001
Iodine I 131 tositumomab for patients with low-grade or transformed low-grade NHL: Complete response data.
2000
Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow
1997
Epstein–Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases
1998
Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products
1998
High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging.
1991
Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents
1992
Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma
1996
Familial haemophagocytic lymphohistiocytosis treated with allogeneic bone marrow transplantation.
1991
Autologous bone marrow transplantation for aggressive non-Hodgkin's lymphoma: issues and controversies.
1991